Aruni Ghose: Evidence OncoFlow at the Heart of Breast Cancer MDT Transformation in the UK
Aruni Ghose/LinkedIn

Aruni Ghose: Evidence OncoFlow at the Heart of Breast Cancer MDT Transformation in the UK

Aruni Ghose, Director and Chief Executive Officer at Canprecise AI, Chief Medical Officer at Shiksak, shared a post on LinkedIn:

“Evidence OncoFlow at the heart of Breast Cancer MDT Transformation in the UK

2 Posters at ESMOBC2026 – watch out for clever Presenters Joecelyn Kirani T. and Disha Khanna

Hailing from the Cohort 9 NHS Clinical Entrepreneur Programme and the Medicines and Healthcare products Regulatory Agency AI Airlock Regulatory Sandbox Testing we showed Streamlining of Case Preparation by Efficient Data Extraction and Treatment Decision Making by Guideline Mapping – A Framework that combined MultiStakeholder Explainability Transparency and LLM Benchmarking

Feel free to reach out to aruni.ghose@oncoflow.co.uk

Fantastic to have conceptualised the Framework with Maryam Hasanova and a significant MultiDisciplinary Team and Stakeholders.

Engineers – Anirudh Shankar and Adan Khan
Abstracting – Olivia B.
GP – Dr Rebecca Pearson
Oncology Pharmacist – Gabriella Langton from The Clatterbridge Cancer Centre NHS Foundation Trust
Breast CNS – Sarah Adomah from The Royal Marsden NHS Foundation Trust
Breast Oncoplastic Surgeons – Urvashi Jain from Manchester University NHS Foundation Trust and Ashutosh Kothari from Guy’s and St Thomas’​ NHS Foundation Trust
Breast Oncologists – Akash Maniam from Portsmouth Hospitals University NHS Trust and Dr Olubukola Ayodele from University Hospitals of Leicester NHS Trust.”

Aruni Ghose: Evidence OncoFlow at the Heart of Breast Cancer MDT Transformation in the UK

Other Articles Featuring Aruni Ghose On OncoDaily.